Anti-neovascular therapy

Maeda, N., Takeuchi, Y., Takada, M., Sadzuka, Y., Namba, Y., and Oku, N. (2004), Anti-neovascular therapy by use of tumour neovasculature-targeted long-circulating liposome, J. Controlled Release, 100,41-52. 

ISO.Asai T et al (2002) Anti-neovascular therapy by liposomal DPP-CNDAC targeted to angiogenic vessels. FEBS Lett 520 167-170... 

Kondo M, Asai T, Katanasaka Y, Sadzuka Y, Tsukada H, Ogino K, Taki T, Baba K, Oku N (2004) Anti-neovascular therapy by Hpo-... 

Yonezawa S, Asai T, Oku N (2007) Effective tumor regression by anti-neovascular therapy in hypovascular orthotopic pancreatic tumor model. J Control Release 118 303-309... 

Shimizu K, Asai T, Fuse C, Sadzuka Y, Sonobe T, Ogino Taki T, Tanaka T, Oku N (2005) Applicability of anti-neovascular therapy to drug-resistant tumor Suppression of drug-resistant P388 tumor growth with neovessel-targeted liposomal adriamycin. Int J Pharm 296 133-141... 

T. Asai, K. Shimazu, M. Kondo, K. Kuromi, K. Watanabe, K. Ogino, T. Taki, S. Shuto, A. Matsuda, and N. Oku Anti-neovascular therapy by bposomal DPP-CNDAC targeted to angiogenic vessel. FEBS Letters 520 (2002) 167-170. 

Ferrara N, Damico L, Shams N, et al (2006) Developmemt of Ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina 26 859-870... 

Eye tech Smdy Group. Anti-vascular endotheUal growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration phase 11 smdy results. Ophthalmology 2003 10 979. 

---